§ Funding Round
Series B funding round for Obsidian Therapeutics raising $120M in September 2021
Series B funding round for Obsidian Therapeutics raising $120M in September 2021
| Investor | Firm Type | Partner |
|---|---|---|
| Organization | — | |
| Organization | — | |
| Organization | — | |
Bristol Myers Squibb | — | — |
Cowen Healthcare Investments | — | — |
| Organization | — | |
Logos Capital | — | — |
| Organization | — | |
| Organization | — | |
Samsara BioCapital | — | — |
| Organization | — | |
Surveyor Capital | — | — |
The Column GroupLEAD | Organization | — |
| Organization | — | |
| Organization | — |
This company has completed 3 funding rounds. Current round is highlighted.
Total Raised
$330.5M
Top Valuation
-
Obsidian Therapeutics raised $120M in a Series B round.
The round was announced on 09/01/21.
The round was led by The Column Group.
